Pharmafile Logo

Gower Publishing

- PMLiVE

Oxford University to study antiparasitic drug ivermectin in COVID-19 trial

The potential COVID-19 treatment will be investigated as part of the large-scale PRINCIPLE trial

- PMLiVE

Global consortium of medicines regulators reveals new strategic plan

Access Consortium includes regulators from Australia, Canada, Singapore, Switzerland and the UK

- PMLiVE

Merck’s Keytruda improves outcomes for metastatic cervical cancer patients

Keytruda improved overall survival and progression-free survival regardless of patients' PD-L1 status

- PMLiVE

Numbers, navigation, and narratives: digital storytelling in medical communications

Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...

Avalere Health

- PMLiVE

Roche’s gantenerumab improves biomarkers in inherited form of Alzheimer’s disease

However, anti-amyloid antibody did not show evidence of cognitive benefit for patients

- PMLiVE

GSK, Vir’s sotrovimab cuts hospitalisation and death risk by 79% in COVID-19 outpatients

Final efficacy analysis confirms previous positive findings from interim analysis

- PMLiVE

Tonix Pharmaceuticals to develop TNX-102 for long COVID syndrome

TNX-102 is already in phase 3 development for the treatment of fibromyalgia

EFPIA appoints Hubertus von Baumbach as president

Von Baumbach will serve as president of the EFPIA for the next two years

- PMLiVE

Nature’s way

There are business lessons to be learned from biological tragedies

MM&M Agency 100

OPEN Health Starring in the Top 100 North American Healthcare Agencies of 2021

We are delighted to announce our selection in the top 50 of 100 North American healthcare agencies as ranked by Medical, Marketing & Media (MM&M).

OPEN Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links